Since pancreatic cancer is often diagnosed in a late state of cancer development, diagnostic opportunities allowing early disease detection are highly sought after. As such, cancer expression of claudin proteins is markedly dysregulated, making it an attractive target for molecular imaging like positron emission tomography (PET). Claudins are a family of transmembrane proteins that have a pivotal role as members of the tight junctions. In particular, claudin-3 and claudin-4 are frequently overexpressed in pancreatic cancer. 18 F-Labeled claudin selective peptides would provide access to a novel kind of imaging tools for pancreatic cancer. In this work we describe the synthesis of the first 18 F-labeled probes potentially suitable for PET imaging of claudin-4 expression. These probes were prepared using oxime ligation of 5-[ 18 F]fluoro-5-deoxyribose (5-[ 18 F]FDR) to claudin selective peptides. As a proof-of-principle, one of them, 5-[ 18 F]FDR-Clone 27, was isolated in >98% radiochemical purity and in 15% radiochemical yield (EOB) within 98 min, and with a molar activity of 4.0 GBq/µmol (for 30 MBq of tracer). Moreover, we present first biological data for the prepared 5-FDR-conjugates. These tracers could pave the way for an early diagnosis of pancreatic tumor, and thus improve the outcome of anticancer therapy.
Introduction
Since pancreatic cancer rarely causes symptoms in early stages, its treatment is often challenging. Usually, if discovered, the tumor is already in a metastatic state and seldom resectable. Only 15-20% of the tumors can be completely removed so that the five-year survival rate for patients with pancreatic cancer is only about 8%. The average life expectancy after detecting tumor metastasis is less than half a year [1, 2] . Thus, early diagnosis of pancreatic cancer is highly important, and different imaging techniques are applied [3] . Besides computed tomography (CT), endoscopic ultrasound (EUS) and magnetic resonance imaging (MRI), positron emission tomography (PET) is also applied. PET is a widely used non-invasive molecular imaging modality in clinical diagnostics. It enables the visualization of physiological and pathological processes in vivo with high resolution by means (Figure 1, compound A) is the most frequently used prosthetic group for peptide labeling. Furthermore, many other aromatic aldehyde functionalized prosthetic groups have been described in the literature. However, the presence of the hydrophobic aromatic moieties may cause an increase of the overall lipophilicity of the radiolabeled biomolecules, and, consequently, adversely affect their pharmacokinetic properties [10, 11] . On the other side, aldose sugars (e.g., glucose, ribose) represent an interesting hydrophilic building block suitable for peptide conjugation. Recently, it has been shown that under appropriate reaction conditions 5-[ 18 F]fluoro-5-deoxy-D-ribose (5-[ 18 F]FDR) can be conjugated to biopolymers much more efficiently and rapidly than other aldoses like 2-FDG [11] .
4-[ 18 F]Fluorobenzaldehyde
Within this study, 5-[ 18 F]FDR was used to prepare 18 F-labeled peptide conjugates with high affinity to claudin-4, a member of the claudin family, which is highly overexpressed in pancreatic tumor tissues. The claudins are transmembrane proteins and important members of the 'tightjunction' (TJ), which regulates the permeability of paracellular barriers [12] . Depending on the cell type, the TJ is differently permeable to solutes and limits diffusion of membrane lipids and proteins through the cell membrane affecting the polarity of cells [13] . Until now, 27 different claudins, having all a similar structure, were identified [14] . They consist of four transmembrane domains, two extracellular and intracellular loops, with the C-and N-terminal domains located in the cytoplasm [15] . The largest extracellular loop (ECL-1) can interact with the ECL-1 of an adjacent cell and thus build a portion of the TJ.
Claudins are promising targets for cancer imaging and therapy, as they are differently expressed in tumors compared to normal tissues. In most tumors (e.g., claudin-1 in breast cancer cells) their expression is reduced, leading to diminished adhesion and deformation of tumor cells [16] . In contrast, in pancreatic cancer cells claudin-4 is overexpressed leading to increased permeability, higher osmotic stress and greater permeation of solutes [17, 18] . The overexpression of claudin-4 begins at a very early stage of cancer progression, precisely within pancreatic intraepithelial (Figure 1, compound A) is the most frequently used prosthetic group for peptide labeling. Furthermore, many other aromatic aldehyde functionalized prosthetic groups have been described in the literature. However, the presence of the hydrophobic aromatic moieties may cause an increase of the overall lipophilicity of the radiolabeled biomolecules, and, consequently, adversely affect their pharmacokinetic properties [10, 11] . On the other side, aldose sugars (e.g., glucose, ribose) represent an interesting hydrophilic building block suitable for peptide conjugation. Recently, it has been shown that under appropriate reaction conditions 5-[ 18 F]fluoro-5-deoxy-D-ribose (5-[ 18 F]FDR) can be conjugated to biopolymers much more efficiently and rapidly than other aldoses like 2-FDG [11] .
Within this study, 5-[ 18 F]FDR was used to prepare 18 F-labeled peptide conjugates with high affinity to claudin-4, a member of the claudin family, which is highly overexpressed in pancreatic tumor tissues. The claudins are transmembrane proteins and important members of the 'tight-junction' (TJ), which regulates the permeability of paracellular barriers [12] . Depending on the cell type, the TJ is differently permeable to solutes and limits diffusion of membrane lipids and proteins through the cell membrane affecting the polarity of cells [13] . Until now, 27 different claudins, having all a similar structure, were identified [14] . They consist of four transmembrane domains, two extracellular and intracellular loops, with the C-and N-terminal domains located in the cytoplasm [15] . The largest extracellular loop (ECL-1) can interact with the ECL-1 of an adjacent cell and thus build a portion of the TJ.
Claudins are promising targets for cancer imaging and therapy, as they are differently expressed in tumors compared to normal tissues. In most tumors (e.g., claudin-1 in breast cancer cells) their expression is reduced, leading to diminished adhesion and deformation of tumor cells [16] . In contrast, in pancreatic cancer cells claudin-4 is overexpressed leading to increased permeability, higher osmotic stress and greater permeation of solutes [17, 18] . The overexpression of claudin-4 begins at a very early stage of cancer progression, precisely within pancreatic intraepithelial neoplasia, the precursor lesion of pancreatic cancer, and thus offers an excellent opportunity for early detection [18] [19] [20] [21] [22] [23] . Recently it has been found that the second loop (ECL-2) of some claudins (such as claudin-4) is a receptor for Clostridium perfringens enterotoxin (CPE). CPE is one of the 13 toxins that are produced by the anaerobic bacterium C. perfringens. It is a 35 kDa polypeptide, which is highly toxic to humans at very low concentrations [24] . Due to the affinity to claudins, CPE could be a potential tool to target pancreatic cancer. However, since CPE is too toxic for many cell studies, Sonoda et al. developed a non-toxic variant (C-CPE) that is a C-terminal fragment of CPE (184-319) still bearing high affinity to claudin-4 (K a 1.0 × 10 8 mol·L −1 ) [25, 26] . On the basis of this sequence, several research groups developed peptides with selectivity towards various claudins. Moreover, by using "phage display" techniques, Ling et al. identified peptides, including CC4P-5, which possess even higher affinity to claudin-4 than C-CPE and analogs thereof [27, 28] .
The aim of this work was the preparation and preliminary biological evaluation of peptide conjugates potentially suitable for PET-imaging of infiltrating pancreatic ductal adenocarcinoma (PDAC), using claudin-4 as a molecular target. To the best of our knowledge, no reliable and efficient radiolabeling method for claudin-4 selective peptide based PET-tracers has been described in literature until now. Recent attempts relied on the use of a [ 111 In]anti-claudin-4 mAb for diagnosis of pancreatic ductal carcinomas [29] , or a [ 64 Cu]-labeled CPE fragment that has been used for ovarian cancer diagnosis [30] . We introduced the 18 F label via oxime ligation between 5-[ 18 F]FDR and aminooxy-functionalized peptides. This radiolabeling strategy described by Li et al. [11] was optimized by us within the current study. We also studied the secondary structure of 5-FDR peptide conjugates in solution and determined their cellular toxicity.
Results and Discussion

Synthesis and Characterization of 5-FDR-Peptides
In recent studies, several claudin-4 selective peptide binders were identified [25] [26] [27] [28] . We used the reported sequences directly for the establishment of a reliable 18 F-labeling strategy. Only peptide 1, namely C-CPE-17, was slightly modified by introducing three lysines at the C-terminal to increase its overall solubility. All peptides were synthesized by standard Fmoc/tBu solid phase peptide synthesis protocols. At the N-terminus we introduced aminooxyacetic acid (AOA) connected with the main peptide sequence via β-alanine as a short spacer. In a first set of experiments, all peptides were coupled with unlabeled 5-FDR to analyze the influence of the sugar residue on secondary structure, as well as cytotoxicity of the conjugates to two different cell lines. The identity and purity of the novel 5-FDR peptide conjugates was confirmed by LC-ESI MS (Table 1 and Figure 2 ). neoplasia, the precursor lesion of pancreatic cancer, and thus offers an excellent opportunity for early detection [18] [19] [20] [21] [22] [23] . Recently it has been found that the second loop (ECL-2) of some claudins (such as claudin-4) is a receptor for Clostridium perfringens enterotoxin (CPE). CPE is one of the 13 toxins that are produced by the anaerobic bacterium C. perfringens. It is a 35 kDa polypeptide, which is highly toxic to humans at very low concentrations [24] . Due to the affinity to claudins, CPE could be a potential tool to target pancreatic cancer. However, since CPE is too toxic for many cell studies, Sonoda et al. developed a non-toxic variant (C-CPE) that is a C-terminal fragment of CPE (184-319) still bearing high affinity to claudin-4 (Ka 1.0 × 10 8 mol·L −1 ) [25, 26] . On the basis of this sequence, several research groups developed peptides with selectivity towards various claudins. Moreover, by using "phage display" techniques, Ling et al. identified peptides, including CC4P-5, which possess even higher affinity to claudin-4 than C-CPE and analogs thereof [27, 28] . The aim of this work was the preparation and preliminary biological evaluation of peptide conjugates potentially suitable for PET-imaging of infiltrating pancreatic ductal adenocarcinoma (PDAC), using claudin-4 as a molecular target. To the best of our knowledge, no reliable and efficient radiolabeling method for claudin-4 selective peptide based PET-tracers has been described in literature until now. Recent attempts relied on the use of a [ 111 In]anti-claudin-4 mAb for diagnosis of pancreatic ductal carcinomas [29] , or a [ 64 Cu]-labeled CPE fragment that has been used for ovarian cancer diagnosis [30] . We introduced the 18 F label via oxime ligation between 5-[ 18 F]FDR and aminooxy-functionalized peptides. This radiolabeling strategy described by Li et al. [11] was optimized by us within the current study. We also studied the secondary structure of 5-FDR peptide conjugates in solution and determined their cellular toxicity.
Results and Discussion
Synthesis and Characterization of 5-FDR-Peptides
In recent studies, several claudin-4 selective peptide binders were identified [25] [26] [27] [28] . We used the reported sequences directly for the establishment of a reliable 18 F-labeling strategy. Only peptide 1, namely C-CPE-17, was slightly modified by introducing three lysines at the C-terminal to increase its overall solubility. All peptides were synthesized by standard Fmoc/tBu solid phase peptide synthesis protocols. At the N-terminus we introduced aminooxyacetic acid (AOA) connected with the main peptide sequence via β-alanine as a short spacer. In a first set of experiments, all peptides were coupled with unlabeled 5-FDR to analyze the influence of the sugar residue on secondary structure, as well as cytotoxicity of the conjugates to two different cell lines. The identity and purity of the novel 5-FDR peptide conjugates was confirmed by LC-ESI MS (Table 1 and To get more insights into the secondary structure of the peptides in solution, CD spectroscopy analysis was performed. In phosphate buffer we recognized the typical spectrum of an unordered conformation for all peptides, while the addition of trifluoroethanol (TFE) supported the formation of a secondary structure. In fact, only the spectra of 5-FDR-C-CPE-17-KKK and 5-FDR-M19 showed values characteristic for the formation of an alpha helix ( Figure 3 ). However, the shorter conjugates, 5-FDR-CC4P-5 and 5-FDR-Clone 27, were still present in random coil structure. This observation can be explained by the short length of their amino acid sequences. To get more insights into the secondary structure of the peptides in solution, CD spectroscopy analysis was performed. In phosphate buffer we recognized the typical spectrum of an unordered conformation for all peptides, while the addition of trifluoroethanol (TFE) supported the formation of a secondary structure. In fact, only the spectra of 5-FDR-C-CPE-17-KKK and 5-FDR-M19 showed values characteristic for the formation of an alpha helix ( Figure 3 ). However, the shorter conjugates, 5-FDR-CC4P-5 and 5-FDR-Clone 27, were still present in random coil structure. This observation can be explained by the short length of their amino acid sequences. 
Preliminary Biological Evaluation
Next, we studied the cytoxicity of the novel 5-FDR coupled peptides in Capan-1 and HT-29 human adenocarcinoma epithelial cells. Both cell lines are reported to overexpress claudin-4 endogenously, albeit to different extents [31] . Toxicity studies were performed by incubating the cells with the 5-FDR peptide conjugates for 24 h. No significant toxic effects were observed within the studied concentration range (10-100 µmol·L −1 ) (Figure 4) . Therefore, all conjugates were suitable for further biological studies.
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Next, we studied the cytoxicity of the novel 5-FDR coupled peptides in Capan-1 and HT-29 human adenocarcinoma epithelial cells. Both cell lines are reported to overexpress claudin-4 endogenously, albeit to different extents [31] . Toxicity studies were performed by incubating the cells with the 5-FDR peptide conjugates for 24 h. No significant toxic effects were observed within the studied concentration range (10-100 µ mol·L −1 ) (Figure 4) . Therefore, all conjugates were suitable for further biological studies. 
Optimization of the Preparation of 5-[ 18 F]FDR Peptide Conjugates
Next, we prepared 5-[ 18 F]FDR using the recently developed 'minimalist' protocol for radiofluorination (Scheme 1) [10, 32] . The term 'minimalist' was coined due to the exceptional simplicity of this protocol. Thus, according to the conventional procedure of nucleophilic radiofluorination [ 18 F]fluoride produced in [ 18 O]H2O is trapped on an anion-exchange resin to remove the bulk of water and then eluted with an aqueous solution of a base, such as K2CO3. Then, phase transfer catalyst such as 2.2.2-cryptand in acetonitrile is usually added and water is removed by tedious and time-consuming (typically, 15-20 min) azeotropic drying. Finally, to obtain the 18 Flabeled target compound, the dried residue of [ 18 F]KF/K2CO3/K2.2.2 complex is taken up in a solution of the precursor in a polar aprotic solvent and heated. In contrast, following the 'minimalist' method, 18 F − is eluted directly with a solution of the corresponding onium salt precursor in MeOH. Low boiling MeOH is completely removed within 3-5 min. Base and other additives are also not required. 
Next, we prepared 5-[ 18 F]FDR using the recently developed 'minimalist' protocol for radiofluorination (Scheme 1) [10, 32] . The term 'minimalist' was coined due to the exceptional simplicity of this protocol. Thus, according to the conventional procedure of nucleophilic radiofluorination [ 18 [33] of up to 60%, along with the formation of 3-5% side product presumably owing to the concurrent SNAr [33] of up to 60%, along with the formation of 3-5% side product presumably owing to the concurrent SNAr Recently, it has been shown that the oxime formation can be significantly accelerated by aniline catalysis [34] [35] [36] . Consequently, the oxime conjugation of 5-[ 18 F]FDR and claudine-4 ligands in anilinium acetate buffer was studied (Table 3, Figure 6 ). Recently, it has been shown that the oxime formation can be significantly accelerated by aniline catalysis [34] [35] [36] . Consequently, the oxime conjugation of 5-[ 18 F]FDR and claudine-4 ligands in anilinium acetate buffer was studied (Table 3, Figure 6 ). Anilinium acetate buffer significantly increased the efficacy of oxime ligation. The desired radiolabeled conjugates were obtained in RCCs of 76-93% at ambient temperature within 10 min of reaction time. Extended reaction times and higher reaction temperature up to 70 °C did not affect the RCCs.
Materials and Methods
Materials
N α -Fmoc-protected amino acids, Oxyma Pure ® , diisopropylcarbodiimide (DIC), trifluoroacetic acid, and 4-(2′,4′-dimethoxyphenyl-Fmoc-aminomethyl)phenoxy (Rink amide) resin were purchased from IRIS Biotech GmbH (Marktredwitz, Germany), Boc-aminooxyacetic acid, bis-Bocaminooxyacetic acid, sodium hydroxide, potassium hydrogen phosphate, potassium dihydrogen phosphate, and HPLC pure water from Merck KgaA (Darmstadt, Germany), tert-butanol, acetic acid, sodium acetate, piperidine and triisopropylsilane (TIS) from Sigma-Aldrich (St. Louis, MO, USA). Diisopropylethylamine (DIPEA) and trifluoroethanol (TFE) were obtained from Alfa Aesar GmbH (Karlsruhe, Germany), 1,2-ethandithiole and thioanisole from Fluka Analytical/Sigma Aldrich (St. Louis, MO, USA), formic acid, ninhydrine, N-methyl-2-pyrrolidone (NMP), phenol from Carl Roth GmbH (Karlsruhe, Germany). Acetonitrile, dichloromethane, diethyl ether, dimethylformamide, ethanol, and methanol were from VWR BDH Prolabo (Radnor, PA, USA). The following side chain protecting groups were used: 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl (Pbf) for Arg; Trityl (Trt) for Asn, His and Gln; tert-Butyl (tBu) for Asp, Ser, Tyr, Thr and Glu; tert-butyloxycarbonyl (Boc) for Lys and Trp.
The following cell media and supplements were used: Dulbecco's modified Eagle's medium (DMEM) with fetal bovine serum (FBS) and McCoy's 5A Medium with FBS. Tissue culture 96-well plates used for resazurin cytotoxicity assay were obtained from Sarstedt Inc. (Newton, MA, USA), cell culture plates 100 × 20 mm were from BD Falcon (Franclin Lakes, NJ, USA).
Peptide Synthesis
All peptides were prepared by using an automated multiple solid-phase peptide synthesizer (Syro, MultiSynTech, Witten, Germany) according to the Fmoc-tBu strategy. The peptides were synthesized as C-terminal amides using the Rink amide resin (0.48 mmol peptide per gram resin). β-Alanine and aminooxyacetic acid were coupled manually to the peptides using 3 eq. of the reagent, 3 eq. Oxyma and 3 eq. DIC for 2 h and the procedure was repeated twice. After the coupling with Anilinium acetate buffer significantly increased the efficacy of oxime ligation. The desired radiolabeled conjugates were obtained in RCCs of 76-93% at ambient temperature within 10 min of reaction time. Extended reaction times and higher reaction temperature up to 70 • C did not affect the RCCs.
Materials and Methods
Materials
N α -Fmoc-protected amino acids, Oxyma Pure ® , diisopropylcarbodiimide (DIC), trifluoroacetic acid, and 4-(2 ,4 -dimethoxyphenyl-Fmoc-aminomethyl)phenoxy (Rink amide) resin were purchased from IRIS Biotech GmbH (Marktredwitz, Germany), Boc-aminooxyacetic acid, bis-Boc-aminooxyacetic acid, sodium hydroxide, potassium hydrogen phosphate, potassium dihydrogen phosphate, and HPLC pure water from Merck KgaA (Darmstadt, Germany), tert-butanol, acetic acid, sodium acetate, piperidine and triisopropylsilane (TIS) from Sigma-Aldrich (St. Louis, MO, USA). Diisopropylethylamine (DIPEA) and trifluoroethanol (TFE) were obtained from Alfa Aesar GmbH (Karlsruhe, Germany), 1,2-ethandithiole and thioanisole from Fluka Analytical/Sigma Aldrich (St. Louis, MO, USA), formic acid, ninhydrine, N-methyl-2-pyrrolidone (NMP), phenol from Carl Roth GmbH (Karlsruhe, Germany). Acetonitrile, dichloromethane, diethyl ether, dimethylformamide, ethanol, and methanol were from VWR BDH Prolabo (Radnor, PA, USA). The following side chain protecting groups were used: 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl (Pbf) for Arg; Trityl (Trt) for Asn, His and Gln; tert-Butyl (tBu) for Asp, Ser, Tyr, Thr and Glu; tert-butyloxycarbonyl (Boc) for Lys and Trp.
Peptide Synthesis
All peptides were prepared by using an automated multiple solid-phase peptide synthesizer (Syro, MultiSynTech, Witten, Germany) according to the Fmoc-tBu strategy. The peptides were synthesized as C-terminal amides using the Rink amide resin (0.48 mmol peptide per gram resin). β-Alanine and aminooxyacetic acid were coupled manually to the peptides using 3 eq. of the reagent, 3 eq. Oxyma and 3 eq. DIC for 2 h and the procedure was repeated twice. After the coupling with aminooxyacetic acid the peptide amides were finally cleaved from the resin using TFA:water:TIS (95:2.5:2.5, v/v/v) or TFA:TIS:EDT (90:3:7, v/v/v), for the peptide containing Trp (CC4P-5). 5 eq. of Boc-aminooxyacetic acid were added in the cleavage cocktail in order to avoid the formation of the acetone adduct with mass +40 [37] . After 3 h at room temperature, the peptides were precipitated in ice cold diethyl ether and then washed and centrifuged five times; the pellet was lyophilized from water:tert-butyl alcohol (3:1 v/v) and analyzed by RP-HPLC-ESI-MS on a Kinetex C18 column (100 × 4.6 mm; 2.6 µm/100 Å) using linear gradients of 10-60% B in A (A = 0.1% FA in water; B = 0.1% FA in acetonitrile) over 20 min and a flow rate of 0.6 mL min −1 . Further purification of the peptides was achieved by preparative HPLC on RP18 Phenomenex column (Jupiter Proteo, 250 × 15 mm, 4 µm/90 Å) using linear gradients of 10-60% B in A (A = 0.1% TFA in water; B = 0.1% TFA in acetonitrile) over 45 min and a flow rate of 6 mL min −1 . All peptides were obtained with purities >95%.
FDR Coupling
The coupling reaction was performed in ammonium acetate buffer 0.2 mol·L −1 at pH 4.6. 1 eq. of the peptide was dissolved in 100 µL buffer (concentration of peptide 2 µM) and 2 eq. of the 5-FDRwater solution were added. The reaction was left shaking for 20 min at 99 • C [38] (see also, Table 3 ).
CD Spectroscopy
CD spectra were recorded from 260 nm to 190 nm at 20 • C using a Jasco J-715 spectropolarimeter purged with N 2 gas. Peptide samples were dissolved in 10 mmol·L −1 sodium phosphate buffer (pH 7) containing 0 or 50% (v/v) TFE. For measuring CD spectra the peptides were dissolved to a final concentration of 20 µmol·L −1 . Each measurement was repeated four times using a sample cell with a path length of 0.1 cm. Instrument parameters were: response time 2 s, scan speed 50 nm/min, sensitivity 100 mdeg, step resolution 0.5 nm and bandwidth 1.0 nm. All CD spectra were corrected by subtraction of the CD spectrum of the solvent to eliminate the interference from cell, solvent, and optical equipment.
Cell Culture
For all cellular assays the cell lines used were Capan-1 and HT-29. All cell experiments were carried out under a laminar flow hood Herasafe. The temperature (37 • C) of all used chemicals was adjusted by Julabo SW22 heating bath. Cell culture was carried out at 5% CO 2 at 37 • C, using 100 × 20 mm Petri dishes.
The medium used for the Capan-1 cells was Dulbecco's modified Eagle's medium (90%) with fetal bovine serum (FBS, 10%) and for the HT-29 cells McCoy's 5A medium (90%) with fetal bovine serum (FBS, 10%).
The cells were cultured up to a density of about 70% (Capan-1) or 80% (HT-29). Subsequently, the medium was removed and the cells washed twice with Dulbecco's phosphate-buffered saline. For detaching the cells 1 mL Trypsin-EDTA solution was evenly distributed on the cells. After 3 min incubation at 37 • C, the cells were resuspended in 9 mL of medium. This concentrated cell suspension was used for all other tests. In order to determine the cell concentration of the solution, a hemocytometer was used: 10 µL of cell solution was added and the number of cells was manually counted. This cell number was multiplied by 10 4 to obtain the concentration per milliliter.
Cytotoxicity Assay
In order to test the influence of the peptides on cell viability, a resazurin-based cytotoxicity assay was performed. 96-well plates were used. First, a cell suspension with a defined concentration (for HT-29 60,000 cells per well; for Capan-1 80,000 cells per well) was placed in the wells and filled with medium (with fetal calf serum, +FCS) reaching a final volume of 200 µL. After 24 h or after reaching a confluence of 60-80% the culture medium was replaced by 100 µL of culture medium (+FCS) with a defined peptide concentration. Cells were incubated for 24 h with the peptide solution. After removing the peptide solution, the cells were washed with Dulbecco's phosphate-buffered saline. Subsequently, the cells were incubated with 10 µL resazurin in 90 µL medium (without fetal calf serum, −FCS) for 1 h. As negative and positive controls, untreated and treated cells (10 min with 70% EtOH in H 2 O) were used. The fluorometrical measurement was performed on a Tecan infinite M200 (Männedorf, Switzerland) at 596 nm with excitation at 550 nm. The toxicity of the peptides was determined for the concentrations 10, 50, and 100 µmol·L −1 .
Synthesis of the Precursor
Dansyl chloride (2.9 g, 10.75 mmol) was added to a stirred ice-cold solution of 1-O-methyl-2,3-O-isopropylidene-D-ribofuranoside (1.7 g, 8.32 mmol) and triethylamine (1.6 g, 15.81 mmol) in CH 2 Cl 2 (25 mL), the cooling bath was removed and the reaction mixture was stirred for further 16 h. The mixture was concentrated under reduced pressure. Et 2 O and H 2 O (100 mL each) were added to the residue, the organic fraction was separated and washed with H 2 O (3 × 20 mL), 5% NaHCO 3 (3 × 20 mL) and brine (2 × 20 mL), then dried and concentrated under reduced pressure. The residue was purified by column chromatography [EtOAc/hexane = 1:4, silica gel (0.1% CaO)] and recrystallization from Et 2 O/pentane gave the desired product (2.85 g, 78%) as a yellow solid. Analysis of the compound was in good agreement to the data recently obtained [10] . GmbH, Eschborn, Germany), washed with methanol (2 mL), and eluted with an onium salt precursor 6 in methanol (500 µL). Methanol was evaporated under argon stream at 60 • C and 500 mbar within 3-5 min. After cooling to room temperature acetonitrile (400 µL) was added and stirred at 120 • C for 20 min. The resulting solution was cooled to room temperature, diluted with 50% acetonitrile and injected into reverse-phase column (Phenomenex Luna C18 (2) MBq, 15% RCY EOB) was isolated using the same column and chromatographic conditions which were applied for analytic HPLC.
Molar Activity Calculation
The molar activity (GBq/µmol) was calculated by dividing the radioactivity of the purified [ 18 F]FDR-AOA-Clone 27 by the amount of the unlabeled tracer determined from the peak area in a UV-HPLC chromatograms (λ = 210 nm). The amount of unlabeled compound was determined from the UV absorbance/concentration calibration curve. The peak area was determined and the amount of carrier was calculated according to the calibration curve.
Conclusions
In this work, we developed a simple and efficient procedure for the preparation of radiofluorinated claudin-4 binding peptides under ambient conditions using oxime ligation with 5-[ 18 F]FDR. We demonstrated that the corresponding peptide conjugates are non-toxic to cells. Consequently, their 18 F-isotopologues can potentially be used for PET-imaging of claudin-4 overexpressing pancreatic tumors. The clinical application of claudine-4 PET imaging could improve diagnosis of pancreatic cancer at an early stage and, ultimately, reduce mortality from this disease.
Supplementary Materials: The following are available online at www.mdpi.com/1424-8247/10/4/99/s1, NMR spectra and HPLC chromatographs of precursors and radiolabeled compounds.
